Literature DB >> 1710109

Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo.

M A Dwyer1, D S Bredt, S H Snyder.   

Abstract

Inhibition of nitric oxide (NO) synthase activity by L-NG-Nitroarginine (NO2Arg) in brain preparations is not reversed by dialysis and is enhanced by prolonged preincubation of NO2Arg with the enzyme. By contrast, the weaker inhibition by NO2Arg of macrophage NO synthase is fully reversible. NO2Arg inhibits NO synthase activity in the brain after i.p. administration of 5 or 50 mg/kg. This in vivo inhibition also appears to be irreversible. The potent in vivo inhibition of central NO synthase by NO2Arg may facilitate studies of the physiologic function of NO as a neuronal messenger.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710109     DOI: 10.1016/0006-291x(91)90403-t

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  62 in total

1.  Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance.

Authors:  Y A Kolesnikov; Y X Pan; A M Babey; S Jain; R Wilson; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Effect of chronic inhibition of nitric oxide synthase on ocular blood flow and glucose metabolism in the rat.

Authors:  C O'Brien; P A Kelly; I M Ritchie
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Authors:  C J Lowenstein; C S Glatt; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rat.

Authors:  H Prast; H Fischer; E Werner; G Werner-Felmayer; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

5.  Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.

Authors:  A S Adeagbo; C R Triggle
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.

Authors:  J B Warren; R K Loi; M L Coughlan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure.

Authors:  P K Moore; R C Babbedge; P Wallace; Z A Gaffen; S L Hart
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Characterization of the binding of [3H]-L-NG-nitro-arginine in rat brain.

Authors:  A D Michel; R K Phul; T L Stewart; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.

Authors:  Y A Kolesnikov; C G Pick; G Ciszewska; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  L-NNA inhibits the histochemical NADPH-d reaction in rat spinal cord neurons.

Authors:  D Blottner; H G Baumgarten
Journal:  Histochem Cell Biol       Date:  1995-05       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.